$12.69
-0.43-3.28%
Last update: Nov 10, 4:00 PM
NeuroPace Inc
NPCENASDAQ
NeuroPace fell 2.5% from $13.45 to $13.12, behind the S&P 500's +10.0%. Its worst day was May 11 (−14.6%), and its low came Oct 16 at $12.24.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
NeuroPace shares rose 13.3%, while the S&P 500 rose 1.5%.
+13.3%, the year's best day · S&P 500 +1.5%
EPS of $-0.08 beat the $-0.15 estimate on $26.6M revenue (est. $25.3M); Q1 revenue guidance of $21.0M–$22.0M against the $25.3M consensus.
Story events cover the past 12 months · Times ET
+0.9% · S&P 500 +0.7%
EPS of $-0.20 beat the $-0.22 estimate on $22.1M revenue (est. $21.6M); FY revenue guidance of $99.0M–$101.0M against the $98.9M consensus.
+0.1% · S&P 500 +0.6%
NeuroPace shares fell 10.9%, while the S&P 500 fell 1.5%.
−10.9% · S&P 500 −1.5%
EPS of $-0.18 beat the $-0.19 estimate on $22.8M revenue (est. $22.7M); FY revenue guidance of $99.5M–$101.5M against the $100.0M consensus.
−3.3% · S&P 500 +0.3%
NeuroPace closed at its lowest level of the year, 9.0% below where the year started.
−4.2% · S&P 500 −1.1%
NeuroPace shares rose 8.4%, while the S&P 500 rose 1.7%.
+8.4% · S&P 500 +1.7%
Where it ended: a close of $13.12 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.10, revenue est. $27.1M).
Nothing in the past 12 months.
All NPCE dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NPCE and SPY from Benzinga historical bars. Not investment advice.
